drug · antibody drug conjugate
farletuzumab ecteribulin
Phase 2updated 3mo agoby Eisai Co Ltd🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying farletuzumab ecteribulin
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that